Novacea, Inc. and Transcept Pharmaceuticals, Inc. to Hold Conference Call to Discuss Signing of Merger Agreement
SOUTH SAN FRANCISCO, CA and PT. RICHMOND, CA--(Marketwire - September 02, 2008) - Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that they have entered into a definitive merger agreement to create a NASDAQ-listed specialty pharmaceutical company focused on developing new patient benefits from novel applications of existing prescription sleep medicine and psychiatry drugs.